Al's Comment:

 I have talked about Val-083 a lot over the last year. The trial is finally open.  This is a great option for recurrent GBM patients with unmethylated MGMT.

---

Posted on: 02/09/2017

Trials Open for Enrollment: Phase II Study of VAL-083 in Patients with MGMT-unmethylated Bevacizumab-naïve Recurrent Glioblastoma Multiforme

 

---

Click HERE to return to brain tumor news headlines.